← FDA Drug Approvals (Drugs@FDA)

CYCLOPHOSPHAMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NEXUS · Approved 2024-10-29

Drug application

FDA Application #

ANDA216783

Application type

Abbreviated New Drug Application (Generic)

Brand name

CYCLOPHOSPHAMIDE

Generic name

CYCLOPHOSPHAMIDE

Active ingredients

CYCLOPHOSPHAMIDE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

NEXUS

Manufacturer

Nexus Pharmaceuticals, LLC

First approval

2024-10-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown